Project Grant K08CA312595
- Federal Project Grant Award Summary The National Cancer Institute awarded the University of Washington $278,494 on August 1, 2025, under the Cancer Research Manpower program (CFDA 93.398) to support a K08 Mentored Research Scientist Development Award. This five-year project, concluding July 31, 2030, funds the career development and research training of an Assistant Professor of Medicine and primary care physician to become an independent clinician investigator specializing in cancer screening...
- Federal Grant Award Summary The National Cancer Institute awarded the University of Chicago a $185,760 Project Grant under the Cancer Research Manpower program (CFDA 93.398) on September 15, 2025, with a completion date of August 31, 2028. The award supports a research project titled "Targeting Glycerol Metabolism in Anti-Tumor Immunity," which investigates the mechanistic relationship between obesity-related metabolic changes and cancer progression, with particular focus on how...
- Federal Project Grant Award Summary The University of Illinois received a $565,909 Project Grant award from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396), effective May 1, 2026 through April 30, 2031. This award funds fundamental research investigating microcalcifications (MCs) in breast cancer through the development and application of engineered mineralized hydrogels that replicate the tumor microenvironment (TME). The research addresses a critical gap...
- Federal Grant Award Summary The National Cancer Institute awarded the University of Illinois a $386,279 Project Grant on July 10, 2025, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop innovative immunotherapy screening capabilities. The grant funds the creation of a microfluidic device cassette and associated functional immune assay protocols designed to enable personalized immunotherapy screening directly on core needle biopsies from cancer patients. This...
- Federal Grant Award Summary The National Cancer Institute awarded a Project Grant totaling $291,498 to the University of Virginia under the Cancer Research Manpower program (CFDA 93.398) effective May 1, 2026, through April 30, 2031. This K08 career development award supports a structured research and mentorship program investigating the obesity paradox in melanoma treatment resistance. The funded research will deliver comprehensive scientific outputs examining how obesity and androgen...
- Federal Grant Award Summary The National Cancer Institute awarded a $371,161 Project Grant to the University of Colorado-Denver under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) on September 1, 2025, for a two-year performance period concluding August 31, 2027. The award funds the development of artificial intelligence (AI) algorithms designed to improve cervical cancer screening in low-resource settings. Specifically, the project will create advanced AI risk stratification...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $197,747 Project Grant awarded on August 6, 2025, by the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398). The I-ACCESS (Improving Affordability in Cancer Care Through Economic Screening and Support) initiative will develop and pilot a screening assessment and referral program designed to proactively identify cancer-related financial hardship in patients across diverse...
- Federal Project Grant Award Summary Rice University received a $104,278 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective January 11, 2026, with completion targeted for June 30, 2026. The award supports the development of an automated multimodal, multiscale deep learning algorithm for cervical cancer screening in low- and middle-income countries (LMICs). Building on existing low-cost multimodal colposcope hardware...
- Federal Grant Award Summary Wayne State University received a $155,000 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded May 1, 2026, with completion targeted for April 30, 2028. The research project addresses cervical cancer (CC) prevention by assessing multi-level predictors of diagnostic follow-up (DFU) attendance after abnormal cervical cancer screening. While the United States has made progress toward human...
- Federal Project Grant Award Summary New York University received a $442,750 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), with performance extending from September 23, 2025 through August 31, 2027. This research initiative delivers a systematic, theory-driven analysis of implementation strategies for cervical cancer control policies in African low- and middle-income countries (LMICs). The project employs a rigorous...
The National Cancer Institute awarded the University of Illinois a K08 Mentored Clinical Scientist Research Career Development Grant totaling $286,638 (awarded May 15, 2026; completion April 30, 2031) under the Cancer Research Manpower program (CFDA 93.398). This award funds the E-GUIDANCE (Evaluation of Guideline-Based Uptake of Indicated Diagnostic Exams After Abnormal Cervical Cancer Screening Test in Safety-Net Settings) project, which develops an intervention to address care delays following abnormal cervical cancer screening results in uninsured patients served by safety-net health systems. The project delivers structured research services following the Obesity-Related Behavioral Intervention Trials (ORBIT) intervention development model. Deliverables include: (1) quantitative investigation of follow-up care patterns after referral from primary to specialty gynecology care; (2) qualitative evaluation of patient-, provider-, and system-level facilitators and barriers to follow-up; (3) synthesis of an evidence-based intervention package targeting identified bottlenecks; and (4) assessment of intervention acceptability and feasibility with key stakeholders. The convergent mixed-methods study leverages the CAPRICORN platform and focuses on reducing cervical cancer incidence and mortality in underserved populations through improved care continuity and guideline-based diagnostic follow-up protocols.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $286.6k | 5/26/26 |